Scaling HCP education is not a content problem

Published on:

Sep 7, 2026

Reading time

Every Medical Affairs and Commercial Excellence team is asked to do the same thing: reach more HCPs, across more specialties and markets, with science that gets more complex and more fragmented every quarter.

The fragmentation is measurable

Biomedical publications grew by more than 200% in twenty years (Ghasemi et al., 2022). That fragmentation makes it harder than ever for HCPs to keep up. And field teams cannot be everywhere.

A PDF, a one-off webinar or a congress booth does not create lasting engagement. So education stays inconsistent, awareness gaps persist, and patients wait longer for the right care.

The harder problem is trust

Volume is the visible problem. It is not the binding one. From your position, you cannot earn HCP trust on your own. That is the constraint every Medical Affairs team works inside, and no amount of content removes it.

Better-informed teams bring more value and credibility to every interaction, giving HCPs more reasons to engage, and re-engage. Credibility is the asset. Content is only the means.

Three questions a clinician asks before reading anything

They are the same in a feed and in a search. Everything we build answers one of them.

1. Is this my subject?

Specialty labels are a poor proxy for practice. Thoracic surgery covers pulmonary, cardiac and vascular work: three activities that do not read the same papers.

Relevance is set on a practice profile, not on a specialty label
The product proposes, the clinician confirms in two taps
All disciplines, 10 languages

The Juisci app: a specialty feed and an in-thread question on the source

2. Is this new to me?

Nothing can be flagged as new without memory of what this clinician has already seen.

What is read informs what is offered next
What is asked of the agent comes back into the feed
The same thread, visit after visit, instead of a session that restarts

3. Is this solid?

This is where transparency is decided, and it covers what a selection leaves out as much as what it surfaces.

Peer-reviewed journals, predatory journals excluded
Journal grade, methodological strength, bias analysis, declared interests
Why a given item was recommended, shown alongside it
Every figure, every conclusion traces back to the original publication
Auditable at any time

How this works in practice

Three patterns we see across the Life Science companies we work with. Named examples are available under NDA.

One market becomes five. A specialty pharma extended a single-country programme across five European markets by localising the scientific content instead of re-creating it, and measuring engagement the same way in each.
A newsletter becomes an always-on space. Another turned a long-standing email into a persistent space, so updates keep reaching the same targeted HCPs over time rather than once per send.
A portal that stays current. A third plugs Juisci into its own HCP portal through an API, so the portal publishes new peer-reviewed science every month, market by market, without its teams writing a line.

What this asks of a sponsor

Supporting scientific education is not the same as distributing a message. Three conditions make it credible to an HCP audience.

Opt-in reach and recurring engagement, rather than an audience bought for the length of a campaign
Ranking that is never influenced by commercial status. Matching is thematic. A sponsor gains visibility on a theme, never priority over the evidence
An environment outside medical device scope, with a documentary purpose. Data hosted in the European Union, GDPR. Selection supervised by our medical team

What it comes down to

Scaling HCP education is not about producing more content. It is about delivering the right science to the right HCP, consistently, and being able to measure it.

What matters, and why.